Show simple item record

dc.contributor.authorByrd, H. C. Michelle
dc.contributor.authorCurtin, Carol
dc.contributor.authorAnderson, S E.
dc.date2022-08-11T08:09:07.000
dc.date.accessioned2022-08-23T16:18:21Z
dc.date.available2022-08-23T16:18:21Z
dc.date.issued2013-12-01
dc.date.submitted2015-03-30
dc.identifier.citation<p>Byrd HC, Curtin C, Anderson SE. Attention-deficit/hyperactivity disorder and obesity in US males and females, age 8-15 years: National Health and Nutrition Examination Survey 2001-2004. Pediatr Obes. 2013 Dec;8(6):445-53. doi: 10.1111/j.2047-6310.2012.00124.x. Epub 2013 Jan 16. PubMed PMID: 23325553; PubMed Central PMCID: PMC3638065. <a href="http://dx.doi.org/10.1111/j.2047-6310.2012.00124.x">Link to article on publisher's site</a></p>
dc.identifier.issn2047-6302 (Linking)
dc.identifier.doi10.1111/j.2047-6310.2012.00124.x
dc.identifier.pmid23325553
dc.identifier.urihttp://hdl.handle.net/20.500.14038/34796
dc.description.abstractWHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: Youth with ADHD may be at increased risk for obesity. Medications used to treat ADHD can affect weight. Few studies have investigated possible gender differences in associations between ADHD and obesity. WHAT THIS STUDY ADDS: Nationally representative of US youth aged 8-15 years. Height and weight were measured, and ADHD assessed by structured diagnostic interview and parent report. Associations between ADHD and obesity are reported for males and females to enable gender comparisons. OBJECTIVE: To investigate how associations between attention-deficit/hyperactivity disorder (ADHD) and obesity differ by gender and medication use in a nationally representative sample of US youth in which height and weight were measured. METHODS: Youth age 8-15 (n = 3050) studied in the National Health and Nutrition Examination Survey 2001-2004. Obesity was defined as >/=95th percentile of US body mass index-for-age reference. ADHD was determined by asking parents if child had been diagnosed and using the Diagnostic Interview Schedule for Children IV. Gender-stratified multivariable logistic regression was used to estimate odds of obesity for youth with ADHD (medicated and unmedicated) relative to youth without ADHD. RESULTS: Males with ADHD who were medicated had lower odds of obesity compared to males without ADHD (adjusted odds ratio [OR] = 0.42, 95% confidence interval [CI] = 0.23-0.78). Unmedicated males with ADHD were as likely as males without ADHD to be obese (adjusted OR = 1.02, 95% CI = 0.43-2.42). The odds of obesity for females taking medication for ADHD did not differ statistically from those of females without ADHD (adjusted OR = 1.21, 95% CI = 0.52-2.81). Females with ADHD not taking medication had odds of obesity 1.54 times those of females without ADHD; however, the 95% CI (0.79-2.98) was wide and not statistically significant at alpha = 0.05. CONCLUSIONS: Associations between ADHD and obesity are influenced by treatment of ADHD with medication and may differ by gender. Youth with ADHD who are not treated with medication are as or more likely than youth without ADHD to be obese. the Study of Obesity.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=23325553&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttp://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638065/
dc.subjectAdolescent
dc.subjectAttention Deficit Disorder with Hyperactivity
dc.subjecttherapy
dc.subjectBody Mass Index
dc.subjectCentral Nervous System Stimulants
dc.subjectChild
dc.subjectCross-Sectional Studies
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectNutrition Surveys
dc.subjectObesity
dc.subjectOdds Ratio
dc.subjectPrevalence
dc.subjectRisk Factors
dc.subjectUnited States
dc.subjectadolescent
dc.subjectAttention-Deficit/Hyperactivity Disorder (ADHD)
dc.subjectgender differences
dc.subjectNational Health and Nutrition Examination Survey (NHANES)
dc.subjectobesity
dc.subjectDiagnosis
dc.subjectDietetics and Clinical Nutrition
dc.subjectGender and Sexuality
dc.subjectMental Disorders
dc.subjectNutritional and Metabolic Diseases
dc.subjectPathological Conditions, Signs and Symptoms
dc.subjectPediatrics
dc.titleAttention-deficit/hyperactivity disorder and obesity in US males and females, age 8-15 years: National Health and Nutrition Examination Survey 2001-2004
dc.typeJournal Article
dc.source.journaltitlePediatric obesity
dc.source.volume8
dc.source.issue6
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/iddrc_pubs/16
dc.identifier.contextkey6919877
html.description.abstract<p>WHAT IS ALREADY KNOWN ABOUT THIS SUBJECT: Youth with ADHD may be at increased risk for obesity. Medications used to treat ADHD can affect weight. Few studies have investigated possible gender differences in associations between ADHD and obesity.</p> <p>WHAT THIS STUDY ADDS: Nationally representative of US youth aged 8-15 years. Height and weight were measured, and ADHD assessed by structured diagnostic interview and parent report. Associations between ADHD and obesity are reported for males and females to enable gender comparisons.</p> <p>OBJECTIVE: To investigate how associations between attention-deficit/hyperactivity disorder (ADHD) and obesity differ by gender and medication use in a nationally representative sample of US youth in which height and weight were measured.</p> <p>METHODS: Youth age 8-15 (n = 3050) studied in the National Health and Nutrition Examination Survey 2001-2004. Obesity was defined as >/=95th percentile of US body mass index-for-age reference. ADHD was determined by asking parents if child had been diagnosed and using the Diagnostic Interview Schedule for Children IV. Gender-stratified multivariable logistic regression was used to estimate odds of obesity for youth with ADHD (medicated and unmedicated) relative to youth without ADHD.</p> <p>RESULTS: Males with ADHD who were medicated had lower odds of obesity compared to males without ADHD (adjusted odds ratio [OR] = 0.42, 95% confidence interval [CI] = 0.23-0.78). Unmedicated males with ADHD were as likely as males without ADHD to be obese (adjusted OR = 1.02, 95% CI = 0.43-2.42). The odds of obesity for females taking medication for ADHD did not differ statistically from those of females without ADHD (adjusted OR = 1.21, 95% CI = 0.52-2.81). Females with ADHD not taking medication had odds of obesity 1.54 times those of females without ADHD; however, the 95% CI (0.79-2.98) was wide and not statistically significant at alpha = 0.05.</p> <p>CONCLUSIONS: Associations between ADHD and obesity are influenced by treatment of ADHD with medication and may differ by gender. Youth with ADHD who are not treated with medication are as or more likely than youth without ADHD to be obese. the Study of Obesity.</p>
dc.identifier.submissionpathiddrc_pubs/16
dc.contributor.departmentShriver Center
dc.contributor.departmentIntellectual and Developmental Disabilities Research Center
dc.source.pages445-53


This item appears in the following Collection(s)

Show simple item record